The NSW Government has committed $72.2 million to build a new Ribonucleic Acid (RNA) Research and Pilot Manufacturing Facility at Macquarie University’s Wallumattagal Campus, on the corner of Culloden and Gymnasium Roads in the Connect Macquarie Park Innovation District.

The new facility will enable the local research, development and production of a broad spectrum of RNA technologies to treat a range of human and animal diseases, disorders and infections. The planning application is expected to be lodged in the coming months with the Department of Planning and Environment with construction scheduled to start in 2024, subject to approval. The facility is expected to be completed and operational in 2025.

Read more about the RNA Research and Pilot Manufacturing Facility.

If you have any questions or would like more information, please contact the project team via hirna@health.nsw.gov.au.